Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 56 entries
View as:

PROFIT - Prostate Fractionated Irradiation Trial

Phase: N/A Priority: Normal
NCT ID: NCT00304759 Org: User:
Start: 05/31/06 End: 07/15/17 Due: 07/15/18

Advanced Lung Cancer Treatment With Metformin and Chemo-Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02115464 Org: User:
Start: 12/17/14 End: 04/21/20 Due: 04/21/21

SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04090710 Org: User:
Start: 01/29/20 End: 04/30/26 Due: 04/30/27

Assessment of New Molecular Imaging Strategies for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02813226 Org: User:
Start: 02/16/17 End: 12/17/21 Due: 12/17/22

Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00156052 Org: User:
Start: 04/30/93 End: 06/30/15 Due: 06/30/16

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Phase: N/A Priority: Normal
NCT ID: NCT05417516 Org: User:
Start: 11/20/23 End: 11/30/31 Due: 11/30/32

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Phase: N/A Priority: Normal
NCT ID: NCT00282035 Org: User:
Start: 01/31/06 End: 03/31/18 Due: 03/31/19

A Decision Aid for Women With Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00201929 Org: User:
Start: 04/30/02 End: 11/30/06 Due: 11/30/07

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01423890 Org: User:
Start: 01/31/12 End: 02/28/14 Due: 02/28/15

Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)

Phase: N/A Priority: Normal
NCT ID: NCT00895349 Org: User:
Start: 04/30/10 End: 08/31/19 Due: 08/31/20

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02751710 Org: User:
Start: 12/06/16 End: 03/31/23 Due: 03/31/24

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

Phase: N/A Priority: Normal
NCT ID: NCT06654336 Org: User:
Start: 07/15/25 End: 06/30/31 Due: 06/30/32

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

Phase: N/A Priority: Normal
NCT ID: NCT04797299 Org: User:
Start: 11/23/22 End: 05/31/35 Due: 05/31/36

Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation

Phase: N/A Priority: Normal
NCT ID: NCT02637024 Org: User:
Start: 05/31/16 End: 12/31/22 Due: 12/31/23

Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00811369 Org: User:
Start: 08/31/09 End: 08/31/13 Due: 08/31/14

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Phase: N/A Priority: Normal
NCT ID: NCT00799136 Org: User:
Start: 02/29/08 End: 09/30/13 Due: 09/30/14

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)

Phase: N/A Priority: Normal
NCT ID: NCT00310232 Org: User:
Start: 02/28/01 End: 04/30/04 Due: 04/30/05

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

Phase: N/A Priority: Normal
NCT ID: NCT00201942 Org: User:
Start: 02/28/05 End: 05/31/07 Due: 05/31/08

Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)

Phase: N/A Priority: Normal
NCT ID: NCT00391248 Org: User:
Start: 11/30/06 End: 12/31/12 Due: 12/31/13

The Roles of Tissue Factor in Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00201903 Org: User:
Start: 01/31/04 End: 10/31/06 Due: 10/31/07

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

Phase: N/A Priority: Normal
NCT ID: NCT00136864 Org: User:
Start: 08/31/04 End: 09/30/11 Due: 09/30/12

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06421675 Org: User:
Start: 03/28/25 End: 12/31/28 Due: 12/31/29

Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01968941 Org: User:
Start: 05/07/14 End: 05/31/22 Due: 05/31/23

Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population

Phase: N/A Priority: Normal
NCT ID: NCT02076672 Org: User:
Start: 11/05/19 End: 04/28/20 Due: 04/28/21

Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)

Phase: N/A Priority: Normal
NCT ID: NCT00307229 Org: User:
Start: 03/31/06 End: 05/31/12 Due: 05/31/13